Human Immunology News 7.26 July 9, 2019 | |
| |
TOP STORYConnecting Blood and Intratumoral Treg Cell Activity in Predicting Future Relapse in Breast Cancer The signaling responsiveness of peripheral blood regulatory T (Treg) II cells to immunosuppressive, T helper type 1 (TH1) and TH2 cytokines reflected intratumoral immunosuppressive potential, and predicted future relapse in two independent cohorts of patients with breast cancer. [Nat Immunol] Abstract | Press Release | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Epigenetic Programming Underpins B Cell Dysfunction in Human SLE Researchers determined the DNA methylomes, chromatin accessibility profiles and transcriptomes from five human B cell subsets, including a newly defined effector B cell subset, from subjects with systemic lupus erythematosus (SLE) and healthy controls. [Nat Immunol] Abstract | Press Release Notch-1 Inhibition Promotes Immune Regulation in Transplantation via Treg-Dependent Mechanisms Scientists investigated the pattern of Notch-1 expression in effector and regulatory T cells (Tregs) in both murine and human recipients of a solid organ transplant. Using a selective human anti-Notch-1 antibody, they examined the effect of Notch-1 receptor inhibition in full MHC-mismatch murine cardiac and lung transplant models, and in a humanized skin transplant model. [Circulation] Abstract NK Cells Switch from Granzyme B to Death Receptor-Mediated Cytotoxicity during Serial Killing Investigators simultaneously measured the activities of granzyme B (GrzB) and caspase-8 in tumor cells upon contact with human natural killer (NK) cells. They observed that NK cells switched from inducing a fast GrzB-mediated cell death in their first killing events to a slow death receptor-mediated killing during subsequent tumor cell encounters. [J Exp Med] Abstract | Graphical Abstract Acute Iron Deprivation Reprograms Human Macrophage Metabolism and Reduces Inflammation In Vivo The authors induced acute iron chelation in primary human macrophages and measured their transcriptional and metabolic responses. Acute iron deprivation caused an anti-proliferative Warburg transcriptome, characterized by an ATF4-dependent signature. [Cell Rep] Full Article | Graphical Abstract Using a T cell-transfer model of experimental autoimmune uveitis, scientists found that IFN-α/β treatment inhibited the migration of IFN-γ-producing pathogenic CD4+ T cells to effector sites. [Cell Rep] Full Article | Graphical Abstract To investigate the impact of STAT3 signaling on B cell responses, researchers assessed lymph node and bone marrow, blood B and plasma cell subsets, somatic hypermutations in Ig genes, in vitro proliferation and antibody production in STAT3‐HIES patients and healthy controls. [Allergy] Abstract Circulating C-X-C motif chemokine receptor type 5-negative, programmed cell death protein 1-positive (CXCR5−PD-1hi) peripheral T helper (Tph) cells shared several features associated with B cell helper function with circulating CXCR5−PD-1hi follicular T helper cells. Moreover, the frequency of circulating Tph cells was increased in children with newly diagnosed type 1 diabetes, especially in those who are positive for multiple autoantibodies. [Diabetologia] Full Article High-Throughput Analysis of the Human Thymic Vδ1+ T Cell Receptor Repertoire Investigators applied next-generation sequencing to analyse the γδ T cell receptor (γδTCR) repertoire of highly purified Vδ1+ T cells from human thymic biopsies. They revealed unsuspected aspects of thymically rearranged and expressed TRG and TRD genes, thus constituting a data resource that qualifies previous conclusions on the TCR repertoire of γδ T cells developing in the human thymus. [Sci Data] Full Article Scientists studied the effects of cigarette smoke on model THP-1 and peripheral blood monocyte derived macrophages, and discovered a marked inhibition of bacterial phagocytosis which was replicated in primary human macrophages. [Sci Rep] Full Article Using tissue explant cultures, researchers found that CD4+CD69+CD103+ tissue-resident memory T cells in human skin could down-regulate CD69 and exit the tissue. [Sci Immunol] Full Article Subscribe to our sister publications: Immunology of Infectious Disease News & Immune Regulation News. | |
| |
REVIEWSThe authors describe the current view of the cellular consequences of B cell antigen receptor signaling and advances in the understanding of B cell signaling in context in vivo. [Nat Immunol] Abstract T Follicular Helper Cells and T Follicular Regulatory Cells in Rheumatic Diseases Evidence indicates that patients with autoimmune rheumatic diseases have increased numbers of T follicular helper (TFH) cells that can be hyperactive, and also potentially have altered numbers of Tf regulatory (TFR) cells with reduced function, suggesting a conceivable dysregulation in the balance between TFH cells and TFR cells in these diseases. [Nat Rev Rheumatol] Abstract Visit our reviews page to see a complete list of reviews in the human immunology research field. | |
| |
INDUSTRY NEWSBe The Match BioTherapies® and Tmunity Therapeutics, Inc. announced a partnership to accelerate patient access to life-saving cell therapies. [BioTherapies®] Press Release Iovance Biotherapeutics, Inc. provided an update on the regulatory path for LN-145 in advanced cervical cancer. [Iovance Biotherapeutics, Inc. (GlobeNewswire, Inc.)] Press Release Unum Therapeutics Announces Regulatory Update from Phase I Trial with ACTR087 Unum Therapeutics Inc. announced that the FDA has placed a clinical hold on the Phase I trial evaluating Unum’s ACTR087 in combination with rituximab following lymphodepleting chemotherapy with fludarabine and cyclophosphamide in patients with relapsed/refractory CD20+ B cell non-Hodgkin lymphoma. [Unum Therapeutics Inc. GlobeNewswire, Inc.)] Press Release Alexion Pharmaceuticals, Inc. announced that the FDA approved SOLIRIS® for the treatment of NMOSD in adult patients who are AQP4 antibody positive. Approximately three quarters of all patients with NMOSD test positive for anti-AQP4 auto-antibodies. [Alexion Pharmaceuticals, Inc.] Press Release Grifols announced that Xembify®, its new 20% subcutaneous immunoglobulin, has been approved by the FDA. [Grifols] Press Release | |
| |
POLICY NEWSHungarian Government Takes Control of Research Institutes despite Outcry After months of struggle between Hungary’s research ministry and its scientific community, the nation’s parliament ratified a law on 2 July that gives the government control over the 40 or so institutes belonging to the Hungarian Academy of Sciences. The government says that its aim is to make research more innovative. [Nature News] Editorial Mexican President Eases Up on Researchers’ Travel Rules A month after announcing increased austerity measures on international travel for scientists, Mexico’s National Council of Science and Technology announced that at least one restriction would be loosened. Scientists would not require presidential approval for every trip abroad. [The Scientist] Editorial
| |
EVENTSNEW British Society for Immunology Congress 2019 Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Position – Mucosal Immunology (University of California San Diego) Postdoctoral Research Scientist – Molecular Immunology (Babraham Institute) PhD Fellowship – Immunology (University of Oslo) Postdoctoral Fellow – Tumor Immunology (Massachusetts General Hospital and Harvard Medical School) Senior Research Assistant – Immunology (MD Anderson Cancer Center) Postdoctoral Fellow – Immunology (Boston University) Postdoctoral Position – Immunology of Enteric Infections (University of Utah) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Human Immunology News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|